We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.27B
AUM Growth
-$287M
Cap. Flow
-$382M
Cap. Flow %
-30.07%
Top 10 Hldgs %
34.31%
Holding
428
New
73
Increased
98
Reduced
156
Closed
77

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$26.5M
2
PFE icon
Pfizer
PFE
+$19.8M
3
SM icon
SM Energy
SM
+$19.7M
4
HD icon
Home Depot
HD
+$14M
5
ASML icon
ASML
ASML
+$11.5M

Top Sells

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$38.2M
2
DVN icon
Devon Energy
DVN
+$20.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$18.4M
4
JPM icon
JPMorgan Chase
JPM
+$17.9M
5
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$16.2M

Sector Composition

Rank Sector Weight
1 Energy 31.08%
2 Technology 12.45%
3 Healthcare 10.63%
4 Industrials 10.2%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCC icon
126
Ares Capital
ARCC
$13.5B
$1.86M 0.15%
88,031
-15,968
-15% -$332K
FRME icon
127
First Merchants
FRME
$2.72B
$1.86M 0.15%
44,389
-145,635
-77% -$6.1M
HBNC icon
128
Horizon Bancorp
HBNC
$1.03B
$1.85M 0.15%
88,905
-165,995
-65% -$3.26M
MDT icon
129
Medtronic
MDT
$107B
$1.85M 0.15%
17,907
+4,306
+32% +$499K
KAI icon
130
Kadant
KAI
$3.69B
$1.83M 0.14%
7,949
-371
-4% -$82.7K
GT icon
131
Goodyear
GT
$2.07B
$1.79M 0.14%
84,117
+25,105
+43% +$521K
ARES icon
132
Ares Management
ARES
$28.5B
$1.77M 0.14%
21,760
+170
+0.8% +$13.8K
LHX icon
133
L3Harris
LHX
$55.9B
$1.74M 0.14%
8,147
+398
+5% +$88.2K
ITCI
134
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.73M 0.14%
33,104
+25,165
+317% +$1.06M
ENVA icon
135
Enova International
ENVA
$5.91B
$1.72M 0.14%
41,903
-16,909
-29% -$641K
ITW icon
136
Illinois Tool Works
ITW
$81.4B
$1.71M 0.13%
6,928
+43
+0.6% +$9.99K
ZNTL icon
137
Zentalis Pharmaceuticals
ZNTL
$308M
$1.66M 0.13%
19,770
+2,480
+14% +$192K
JNJ icon
138
Johnson & Johnson
JNJ
$635B
$1.66M 0.13%
9,703
-112,259
-92% -$18.4M
IGIB icon
139
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
$1.66M 0.13%
27,940
+12,670
+83% +$754K
UPST icon
140
Upstart Holdings
UPST
$2.58B
$1.65M 0.13%
10,934
-2,501
-19% -$625K
VGSH icon
141
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$1.64M 0.13%
26,995
+11,460
+74% +$701K
SNA icon
142
Snap-on
SNA
$20.9B
$1.62M 0.13%
7,534
-64,972
-90% -$13.9M
HEES
143
DELISTED
H&E Equipment Services
HEES
$1.62M 0.13%
+36,533
New +$1.59M
FND icon
144
Floor & Decor
FND
$5.81B
$1.59M 0.13%
12,218
-2,225
-15% -$287K
HTGC icon
145
Hercules Capital
HTGC
$2.94B
$1.58M 0.12%
95,094
-14,454
-13% -$245K
DCBO
146
Docebo
DCBO
$492M
$1.57M 0.12%
23,376
+3,451
+17% +$248K
VEA icon
147
Vanguard FTSE Developed Markets ETF
VEA
$226B
$1.57M 0.12%
30,809
PCN
148
PIMCO Corporate & Income Strategy Fund
PCN
$870M
$1.54M 0.12%
90,000
BEAM icon
149
Beam Therapeutics
BEAM
$2.58B
$1.53M 0.12%
19,192
-11,351
-37% -$972K
TGH
150
DELISTED
Textainer Group Holdings limited
TGH
$1.53M 0.12%
42,814
-17,695
-29% -$641K

Similar funds

Advisory Research's Q4 2021 Portfolio in Review

As of Q4 2021, Advisory Research held 428 positions worth $1.27B, down 18% from $1.56B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Advisory Research withdrew a net $382M in Q4 2021, closing 77 positions and reducing 156 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Energy at 31% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advisory Research opened a new position in Moelis & Co worth $4.4M.

  • Advisory Research's largest Q4 2021 buy was Moelis & Co: 70,442 shares worth $4.4M.
  • Advisory Research added most to Coterra Energy in Q4 2021, an estimated $26.5M increase.
  • Advisory Research's biggest Q4 2021 reduction was EQT Corp, cutting an estimated $38.2M.
  • Advisory Research fully exited Terminix Global Holdings, Inc. in Q4 2021, selling an estimated $11M.
  • Advisory Research's ten largest holdings make up 34% of its $1.27B portfolio in Q4 2021.
  • Advisory Research opened 73 new positions and closed 77 in Q4 2021.
  • Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.27B.

Based on Advisory Research's 13F filing for Q4 2021, filed 11 Feb 2022.